RecruitingNot ApplicableNCT06586021

Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall

SEAL - Safety & Feasibility Evaluation of the Aortoseal™ for Seal and Fixation of Abdominal Aortic Aneurysms (AAA) Endovascular Grafts to the Aortic Wall"

Sponsor

Endoron Medical

Enrollment

25 participants

Start Date

Feb 6, 2024

Study Type

INTERVENTIONAL

Conditions

Abdominal Aortic Aneurysm (AAA)

Summary

The Aortoseal Endostapling System is indicated in patients undergoing, or having undergone, treatment of an abdominal aortic aneurysm (AAA) with an endovascular graft to provide enhanced fixation and apposition to the aorta.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Aortoseal Endostapling System for people with abdominal aortic aneurysm (aaa). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAortoseal Endostapling System

Aortoseal Endostapling System

Locations(1)

Sentara Health Research Center

Norfolk, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06586021

Related Trials

The Metformin Aneurysm Trial

ACTRN1261800170725727 locations